0001651308-21-000230.txt : 20211119 0001651308-21-000230.hdr.sgml : 20211119 20211119181842 ACCESSION NUMBER: 0001651308-21-000230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211117 FILED AS OF DATE: 20211119 DATE AS OF CHANGE: 20211119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huang Jane CENTRAL INDEX KEY: 0001683913 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37686 FILM NUMBER: 211429701 MAIL ADDRESS: STREET 1: C/O MOURANT OZANNES CORPORATE SERVICES STREET 2: 94 SOLARIS AVENUE CITY: CAMANA BAY, GRAND CAYMAN STATE: E9 ZIP: KY1-1108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BeiGene, Ltd. CENTRAL INDEX KEY: 0001651308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981209416 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 BUSINESS PHONE: 13459494123 MAIL ADDRESS: STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN) STREET 2: 94 SOLARIS AVENUE, CAMANA BAY CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1108 4 1 wf-form4_163736390377799.xml FORM 4 X0306 4 2021-11-17 0 0001651308 BeiGene, Ltd. BGNE 0001683913 Huang Jane C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108 CAYMAN ISLANDS 0 1 0 0 CMO, Hematology Ordinary Shares 145235 D American Depositary Shares 2021-11-17 4 M 0 1500 119.96 A 1500 D American Depositary Shares 2021-11-17 4 S 0 200 376.155 D 1300 D American Depositary Shares 2021-11-17 4 S 0 300 377.14 D 1000 D American Depositary Shares 2021-11-17 4 S 0 100 377.92 D 900 D American Depositary Shares 2021-11-17 4 S 0 100 379.8839 D 800 D American Depositary Shares 2021-11-17 4 S 0 200 381.41 D 600 D American Depositary Shares 2021-11-17 4 S 0 100 382.42 D 500 D American Depositary Shares 2021-11-17 4 S 0 100 384.16 D 400 D American Depositary Shares 2021-11-17 4 S 0 100 385.28 D 300 D American Depositary Shares 2021-11-17 4 S 0 300 387.94 D 0 D Share Option (Right to Buy) 9.23 2021-11-17 4 M 0 19500 0 D 2029-06-04 Ordinary Shares 19500.0 230776 D Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.76 to $376.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.89 to $377.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.61 to $380.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.82 to $388.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. /s/ Qing Nian, as Attorney-in-Fact 2021-11-19